CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: Triptorelin for Ovary Protection in Childhood Onset Lupus [Phase 2]
Summary
Phase 2 clinical trial evaluating triptorelin for ovary protection in childhood-onset systemic lupus erythematosus has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2021-01-05